Bayer traded at 57.79 this Friday June 24th, decreasing 0.75 or 1.28 percent since the previous trading session. Looking back, over the last four weeks, Bayer lost 9.39 percent. Over the last 12 months, its price rose by 11.59 percent. Looking ahead, we forecast Bayer to be priced at 60.34 by the end of this quarter and at 54.15 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
57.79
Daily Change
-1.28%
Yearly
11.59%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 34.48 1.37 4.14% -36.29%
Air Liquide 134.90 5.18 3.99% -9.85%
Arkema 89.62 3.90 4.55% -15.33%
Akzo Nobel 64.48 2.18 3.50% -39.31%
Alcon AG 66.14 1.40 2.16% 2.45%
Amarin 1.92 -0.07 -3.52% -58.44%
Artemis Alpha 301.00 2.00 0.67% -30.00%
AstraZeneca 10,776.00 396.00 3.82% 26.79%
BASF 42.22 0.79 1.89% -36.09%
Bayer 57.79 -0.75 -1.28% 11.59%
Beiersdorf 97.98 1.30 1.34% -3.89%
Corteva Inc 53.56 2.63 5.16% 21.29%
Vinci 87.75 2.55 2.99% -5.91%
DSM 137.75 7.35 5.64% -12.60%
Essilor 146.55 5.00 3.53% -5.77%
Fresenius Medical Care 47.09 0.93 2.01% -32.77%
Fresenius 28.10 0.54 1.96% -36.83%
Genmab 2,232.00 69.00 3.19% -14.48%
Givaudan 3,310.00 155.00 4.91% -23.79%
GRIFOLS 18.53 -0.09 -0.46% -18.23%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Henkel 60.36 0.82 1.38% -32.78%
Hikma Pharmaceutical 1,637.00 90.50 5.85% -32.33%
Johnson Matthey 1,985.50 38.00 1.95% -35.58%
Linde 283.30 1.20 0.43% 18.98%
Lonza Group 512.80 24.80 5.08% -22.42%
Merck 164.80 8.70 5.57% 4.01%
Novartis 80.60 2.37 3.03% -4.80%
Nutrien Ltd 103.45 0.91 0.89% 37.66%
Philips 20.61 1.06 5.43% -51.39%
PPG Industries 121.01 6.65 5.82% -27.63%
Roche Holding 318.80 12.50 4.08% -7.54%
Sanofi 100.56 4.81 5.02% 13.95%
SAP 92.33 2.95 3.30% -21.54%
Solvay 79.76 2.80 3.64% -26.05%
UCB 80.94 -0.74 -0.91% -6.71%
Umicore 32.54 0.07 0.22% -34.50%

Indexes Price Day Year
EU50 3533 96.88 2.82% -14.26%
DE40 13118 205.54 1.59% -15.95%

Bayer
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non